PARIS - Flamel Technologies SA and Bristol-Myers Squibb Co. signed a licensing and commercialization agreement covering Flamel's human insulin product, Basulin. (BioWorld International)
PARIS - NicOx SA and Merck & Co. Inc. signed an agreement allowing Merck to evaluate certain nitric oxide-donating compounds under NicOx's intellectual property rights. (BioWorld International)
PARIS - NicOx SA and Merck & Co. Inc. signed an agreement allowing Merck to evaluate certain nitric oxide-donating compounds under NicOx's intellectual property rights. (BioWorld International)
